top_bg_history_2x.png

History

bg_history_2x.png

2019

bg_history_fluid.png
History

06 Founded ImmunoBiome, Inc.

07 Seed Financing

10 Obtained certification of a

      Venture company

12 Pre-A Series Financing

      Technology transfers from

      IBS and POSTECH

2020

02 Established the corporate

      affiliated research center

08 Moved the headquarters to Bio

      Open Innovation Center

09 Series-A Financing

10 Signed CDMO contract with Biose

      Industrie, a French company

2021

05 Conducted pre-clinical study for

      IMB002

06 Completed pre-clinical study for

      IMB001

09 MOU for co-development with Hy

      (former Korea Yogurt)

2022

08 IMB002 Preclinical trial

      completion

10 IMB002 cGMP production

      completion

What's Next?